Montelukast Prescribing at DR MAASSARANI & PARTNERS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,075
Total Quantity
30.3K
NHS Cost
£1.6K
vs National Avg
+57%
DR MAASSARANI & PARTNERS prescribed 1,075 items of Montelukast over the last 12 months at a cost of £1,571 to the NHS. This is 57% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
101
Jul 2026
87
Jul 2026
96
Jul 2026
93
Jul 2026
91
Jul 2026
89
Jul 2026
95
Jul 2026
83
Jul 2026
96
Jul 2026
81
Jul 2026
83
Jul 2026
80
Prescribing Details
| Total Items | 1,075 |
|---|---|
| Total Quantity | 30,303 |
| Total NHS Cost | £1,571 |
| Presentations | 4 different forms |
| vs National Average | +57% |
Montelukast Prescribing Comparison
| This practice | 1,075 items |
|---|---|
| National average per practice | 685 items |
| Difference | +57% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.